Xuebijing injection, a Chinese patent medicine, against severe pneumonia: Current research progress and future perspectives
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Xuebijing injection, a Chinese patent medicine, against severe pneumonia: Current research progress and future perspectives
Authors
Keywords
-
Journal
Journal of Integrative Medicine-JIM
Volume 21, Issue 5, Pages 413-422
Publisher
Elsevier BV
Online
2023-08-12
DOI
10.1016/j.joim.2023.08.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity
- (2021) Héloïse Flament et al. NATURE IMMUNOLOGY
- The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: A prospective randomized controlled trial
- (2021) Zhijian Luo et al. European Journal of Integrative Medicine
- Network pharmacology and RNA-sequencing reveal the molecular mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction
- (2021) Ding-Dong He et al. COMPUTERS IN BIOLOGY AND MEDICINE
- Network pharmacology to explore the anti-inflammatory mechanism of Xuebijing in the treatment of sepsis
- (2021) Wuai Zhou et al. PHYTOMEDICINE
- Xuebijing Protects Against Septic Acute Liver Injury Based on Regulation of GSK-3β Pathway
- (2021) Liping Cao et al. Frontiers in Pharmacology
- Xuebijing injection in septic rats mitigates kidney injury, reduces cortical microcirculatory disorders, and suppresses activation of local inflammation
- (2021) Jingfeng Liu et al. JOURNAL OF ETHNOPHARMACOLOGY
- Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms
- (2021) Kai Huang et al. PHARMACOLOGY & THERAPEUTICS
- Traditional Chinese medicine in COVID-19
- (2021) Ming Lyu et al. Acta Pharmaceutica Sinica B
- Mechanistic Investigation of Xuebijing for Treatment of Paraquat-Induced Pulmonary Fibrosis by Metabolomics and Network Pharmacology
- (2021) Tongtong Wang et al. ACS Omega
- Research Progress in Chinese Herbal Medicines for Treatment of Sepsis: Pharmacological Action, Phytochemistry, and Pharmacokinetics
- (2021) Chen Cheng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice
- (2021) Gema M. Olivarria et al. JOURNAL OF VIROLOGY
- Effect of paeoniflorin on acute lung injury induced by influenza A virus in mice. Evidences of its mechanism of action
- (2021) Wendi Yu et al. PHYTOMEDICINE
- Evolution and function of interleukin-4 receptor signaling in adaptive immunity and neutrophils
- (2020) Lukas E. M. Heeb et al. GENES AND IMMUNITY
- Three Ingredients of Safflower Alleviate Acute Lung Injury and Inhibit NET Release Induced by Lipopolysaccharide
- (2020) Yun-peng Wang et al. MEDIATORS OF INFLAMMATION
- Xuebijing Injection Maintains GRP78 Expression to Prevent Candida albicans–Induced Epithelial Death in the Kidney
- (2020) Ting Shang et al. Frontiers in Pharmacology
- Xuebijing Injection Alleviates Pam3CSK4-Induced Inflammatory Response and Protects Mice From Sepsis Caused by Methicillin-Resistant Staphylococcus aureus
- (2020) Tiantian Li et al. Frontiers in Pharmacology
- SARS-CoV-2 and viral sepsis: observations and hypotheses
- (2020) Hui Li et al. LANCET
- Core Outcome Set for Clinical Trials of COVID-19 Based on Traditional Chinese and Western Medicine
- (2020) Ruijin Qiu et al. Frontiers in Pharmacology
- Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
- (2020) Alessio Mazzoni et al. JOURNAL OF CLINICAL INVESTIGATION
- Effects of four types of integrated Chinese and Western medicines for the treatment of COVID-19 in China: a network meta-analysis
- (2020) Lairun Jin et al. Revista da Associacao Medica Brasileira
- Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19
- (2020) Francesco De Virgiliis et al. Nature Reviews Neurology
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Examining the effector mechanisms of Xuebijing injection on COVID-19 based on network pharmacology
- (2020) Wen-jiang Zheng et al. BioData Mining
- The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19
- (2020) Gideon Schreiber Frontiers in Immunology
- Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis
- (2020) Ricardo J. José et al. European Respiratory Review
- Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6
- (2020) Wen-hao Niu et al. BIOSCIENCE REPORTS
- Cytokine Storm
- (2020) David C. Fajgenbaum et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gallic Acid Alleviates Gouty Arthritis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Through Enhancing Nrf2 Signaling
- (2020) Yuqing Lin et al. Frontiers in Immunology
- A Combination of Ulinastatin and Xuebijing Amplifies Neuroprotection after Transient Cerebral Ischemia via Attenuating Apoptosis Signal Pathways in Hippocampus
- (2019) Chi Ma et al. CURRENT PHARMACEUTICAL DESIGN
- Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-κB pathways
- (2019) Huahong Yang et al. Cell Communication and Signaling
- XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia
- (2019) Yuanlin Song et al. CRITICAL CARE MEDICINE
- P2X7 receptor induces mitochondrial failure in monocytes and compromises NLRP3 inflammasome activation during sepsis
- (2019) Juan José Martínez-García et al. Nature Communications
- Natural Killer Cells in the Lungs
- (2019) Jingjing Cong et al. Frontiers in Immunology
- Ablation of endothelial Pfkfb3 protects mice from acute lung injury in LPS-induced endotoxemia
- (2019) Lina Wang et al. PHARMACOLOGICAL RESEARCH
- Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats
- (2018) Ming Jin et al. Chinese Journal of Integrative Medicine
- Anti-sepsis protection of Xuebijing injection is mediated by differential regulation of pro- and anti-inflammatory Th17 and T regulatory cells in a murine model of polymicrobial sepsis
- (2018) Xi Chen et al. JOURNAL OF ETHNOPHARMACOLOGY
- Efficacy and safety of Xuebijing injection (a Chinese patent) for sepsis: A meta-analysis of randomized controlled trials
- (2018) Chengyu Li et al. JOURNAL OF ETHNOPHARMACOLOGY
- Microcirculatory Disorders and Protective Role of Xuebijing in Severe Heat Stroke
- (2018) Hui Jin et al. Scientific Reports
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
- (2017) Rudragouda Channappanavar et al. Seminars in Immunopathology
- Discovery of Xuebijing Injection Exhibiting Protective Efficacy on Sepsis by Inhibiting the Expression of HMGB1 in Septic Rat Model Designed by Cecal Ligation and Puncture
- (2016) Shengguang Chen et al. AMERICAN JOURNAL OF THERAPEUTICS
- Increasing Regulatory T Cells With Interleukin-2 and Interleukin-2 Antibody Complexes Attenuates Lung Inflammation and Heart Failure ProgressionNovelty and Significance
- (2016) Huan Wang et al. HYPERTENSION
- Protective effect of Xuebijing injection on D-galactosamine- and lipopolysaccharide-induced acute liver injury in rats through the regulation of p38 MAPK, MMP-9 and HO-1 expression by increasing TIPE2 expression
- (2016) Ming-Wei Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
- (2016) Mervyn Singer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of Xuebijing injection on microcirculation in septic shock
- (2016) Liang Wang et al. JOURNAL OF SURGICAL RESEARCH
- The pulmonary endothelium in acute respiratory distress syndrome: insights and therapeutic opportunities
- (2016) Fraser R Millar et al. THORAX
- Xuebijing injection alleviates cytokine-induced inflammatory liver injury in CLP-induced septic rats through induction of suppressor of cytokine signaling 1
- (2016) Ailin Li et al. Experimental and Therapeutic Medicine
- The cytokine storm of severe influenza and development of immunomodulatory therapy
- (2015) Qiang Liu et al. Cellular & Molecular Immunology
- Chinese Herbal Preparation Xuebijing Potently Inhibits Inflammasome Activation in Hepatocytes and Ameliorates Mouse Liver Ischemia-Reperfusion Injury
- (2015) Xiqiang Liu et al. PLoS One
- Protective effect of Xuebijing injection on paraquat-induced pulmonary injury via down-regulating the expression of p38 MAPK in rats
- (2015) Ming-wei Liu et al. BMC Complementary and Alternative Medicine
- Heat Stress-Induced Disruption of Endothelial Barrier Function Is via PAR1 Signaling and Suppressed by Xuebijing Injection
- (2015) Qiulin Xu et al. PLoS One
- Treatment Effects of Xuebijing Injection in Severe Septic Patients with Disseminated Intravascular Coagulation
- (2014) Qin Yin et al. Evidence-based Complementary and Alternative Medicine
- T cell-mediated immune response to respiratory coronaviruses
- (2014) Rudragouda Channappanavar et al. IMMUNOLOGIC RESEARCH
- Regulation of NF-κB by TNF family cytokines
- (2014) Matthew S. Hayden et al. SEMINARS IN IMMUNOLOGY
- Xuebijing injection improves the respiratory function in rabbits with oleic acid-induced acute lung injury by inhibiting IL-6 expression and promoting IL-10 expression at the protein and mRNA levels
- (2014) YUXIA WANG et al. Experimental and Therapeutic Medicine
- Effect of Xuebijing injection (血必净注射液) on systemic lupus erythematosus in mice
- (2013) Yan-bo Wang et al. Chinese Journal of Integrative Medicine
- Xuebijing Protects Rats from Sepsis Challenged withAcinetobacter baumanniiby Promoting Annexin A1 Expression and Inhibiting Proinflammatory Cytokines Secretion
- (2013) Xian-Di He et al. Evidence-based Complementary and Alternative Medicine
- Identification of NF-κB Inhibitors in Xuebijing injection for sepsis treatment based on bioactivity-integrated UPLC-Q/TOF
- (2013) Min Jiang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Safflor yellow B suppresses angiotensin II-mediated human umbilical vein cell injury via regulation of Bcl-2/p22phox expression
- (2013) Chaoyun Wang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Reflex Principles of Immunological Homeostasis
- (2012) Ulf Andersson et al. Annual Review of Immunology
- Reactive Oxygen Species in Health and Disease
- (2012) Assim A. Alfadda et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Complement Activation Product C5a Is a Selective Suppressor of TLR4-Induced, but Not TLR3-Induced, Production of IL-27(p28) from Macrophages
- (2012) M. Bosmann et al. JOURNAL OF IMMUNOLOGY
- Integrated Clinical, Pathologic, Virologic, and Transcriptomic Analysis of H5N1 Influenza Virus-Induced Viral Pneumonia in the Rhesus Macaque
- (2012) K. Shinya et al. JOURNAL OF VIROLOGY
- Into the Eye of the Cytokine Storm
- (2012) J. R. Tisoncik et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- New insights for C5a and C5a receptors in sepsis
- (2012) Chunguang Yan et al. Frontiers in Immunology
- Neutrophil-derived ROS contribute to oxidative DNA damage induction by quartz particles
- (2010) Damien van Berlo et al. FREE RADICAL BIOLOGY AND MEDICINE
- The C5a Receptor (C5aR) C5L2 Is a Modulator of C5aR-mediated Signal Transduction
- (2010) Claire E. Bamberg et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of Nrf2 in Endothelial Cells Protects Arteries From Exhibiting a Proinflammatory State
- (2009) Mustafa Zakkar et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The Intracellular Sensor NLRP3 Mediates Key Innate and Healing Responses to Influenza A Virus via the Regulation of Caspase-1
- (2009) Paul G. Thomas et al. IMMUNITY
- DNA Damage and Repair
- (2008) Lee J. Martin JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Metabolic Modulation of Inflammation-Induced Activation of Coagulation
- (2008) Marcel Levi et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started